Browse by author
Lookup NU author(s): Professor Linda Sharp
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
©2017 Frontline Medical Communications. Background Prostate cancer treatments are associated with after-effects that adversely affect men’s health-related quality of life long into survivorship. Objective To investigate the use of supportive medications and interventions in a population-based study of prostate cancer survivors Methods A cross-sectional postal questionnaire was sent to 6,559 prostate cancer survivors (ICD10 C61) who were 2-18 years post diagnosis, identified through population-based cancer registries in Ireland. Information was sought on after-effects that had been experienced at any time after treatment and any medication or intervention received to alleviate symptoms. The Decisional Regret Scale was used to measure survivors’ regret over their entire treatment experience. Chi-square tests were used to investigate variations in receipt of these medications or interventions. Results In a population-based study of prostate cancer survivors (n = 3,364), use of supportive medications/interventions was low. Younger men more often used medications/interventions for impotence and depression, older men for bowel problems and incontinence. 35.6% of survivors reported any decisional regret, significantly higher among those taking supportive medications/ interventions for impotence. Limitations The study is descriptive, survivors were not asked if the supportive care received matched their needs and whether they were satisfied with their supportive care. Conclusions This study documents, for the first time, population-based data on patient-reported use of supportive medications and interventions to alleviate adverse effects of prostate cancer and its treatment. Increased used of medications/interventions for treatment after-effects could improve survivor quality of life.
Author(s): Drummond FJ, Gavin AT, Sharp L
Publication type: Article
Publication status: Published
Journal: Journal of Community and Supportive Oncology
Year: 2017
Volume: 15
Issue: 6
Pages: e309-e313
Print publication date: 01/11/2017
Online publication date: 15/12/2017
Acceptance date: 21/11/2017
ISSN (print): 2330-7749
ISSN (electronic): 2330-7757
Publisher: Frontline Medical Communications
URL: https://www.mdedge.com/jcso/article/154607/genitourinary-cancer/supportive-medications-and-interventions-received-prostate
DOI: 10.12788/jcso.0384
Altmetrics provided by Altmetric
